Identifying cross-disease components of genetic risk across hospital data in the UK Biobank.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
01 2020
Historique:
received: 25 03 2019
accepted: 18 11 2019
pubmed: 25 12 2019
medline: 9 4 2020
entrez: 25 12 2019
Statut: ppublish

Résumé

Genetic risk factors frequently affect multiple common human diseases, providing insight into shared pathophysiological pathways and opportunities for therapeutic development. However, systematic identification of genetic profiles of disease risk is limited by the availability of both comprehensive clinical data on population-scale cohorts and the lack of suitable statistical methodology that can handle the scale of and differential power inherent in multi-phenotype data. Here, we develop a disease-agnostic approach to cluster the genetic risk profiles for 3,025 genome-wide independent loci across 19,155 disease classification codes from 320,644 participants in the UK Biobank, representing a large and heterogeneous population. We identify 339 distinct disease association profiles and use multiple approaches to link clusters to the underlying biological pathways. We show how clusters can decompose the variance and covariance in risk for disease, thereby identifying underlying biological processes and their impact. We demonstrate the use of clusters in defining disease relationships and their potential in informing therapeutic strategies.

Identifiants

pubmed: 31873298
doi: 10.1038/s41588-019-0550-4
pii: 10.1038/s41588-019-0550-4
pmc: PMC6974401
mid: EMS84971
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

126-134

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204290/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12010/3
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 100956
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 090532
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00008/3
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 100308
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204290
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_12028
Pays : United Kingdom

Références

Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015).
pubmed: 26414676 pmcid: 4797329 doi: 10.1038/ng.3406
Pickrell, J. K. et al. Detection and interpretation of shared genetic influences on 42 human traits. Nat. Genet. 48, 709–717 (2016).
pubmed: 27182965 pmcid: 5207801 doi: 10.1038/ng.3570
Malik, R. et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat. Genet. 50, 524–537 (2018).
pubmed: 29531354 pmcid: 5968830 doi: 10.1038/s41588-018-0058-3
Warren, H. R. et al. Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat. Genet. 49, 403–415 (2017).
pubmed: 28135244 pmcid: 5972004 doi: 10.1038/ng.3768
Lee, S. H. et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45, 984–994 (2013).
pubmed: 23933821 doi: 10.1038/ng.2805
Ellinghaus, D. et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat. Genet. 48, 510–518 (2016).
pubmed: 26974007 pmcid: 4848113 doi: 10.1038/ng.3528
Parkes, M., Cortes, A., van Heel, D. A. & Brown, M. A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14, 661–673 (2013).
pubmed: 23917628 doi: 10.1038/nrg3502 pmcid: 23917628
Inshaw, J. R. J., Cutler, A. J., Burren, O. S., Stefana, M. I. & Todd, J. A. Approaches and advances in the genetic causes of autoimmune disease and their implications. Nat. Immunol. 19, 674–684 (2018).
pubmed: 29925982 doi: 10.1038/s41590-018-0129-8
Cortes, A. et al. Bayesian analysis of genetic association across tree-structured routine healthcare data in the UK Biobank. Nat. Genet. 49, 1311–1318 (2017).
pubmed: 28759005 pmcid: 5580804 doi: 10.1038/ng.3926
Oprea, T. I. et al. Unexplored therapeutic opportunities in the human genome. Nat. Rev. Drug Discov. 17, 317–332 (2018).
pubmed: 29472638 pmcid: 6339563 doi: 10.1038/nrd.2018.14
Dendrou, C. A. et al. Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity. Sci. Transl. Med. 8, 363ra149 (2016).
pubmed: 27807284 pmcid: 5737835 doi: 10.1126/scitranslmed.aag1974
Beecham, A. H. et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45, 1353–1360 (2013).
pubmed: 24076602 pmcid: 3832895 doi: 10.1038/ng.2770
Cortes, A. et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat. Genet. 45, 730–738 (2013).
pubmed: 23749187 pmcid: 3757343 doi: 10.1038/ng.2667
Timpson, N. J., Greenwood, C. M. T., Soranzo, N., Lawson, D. J. & Richards, J. B. Genetic architecture: the shape of the genetic contribution to human traits and disease. Nat. Rev. Genet. 19, 110–124 (2018).
pubmed: 29225335 doi: 10.1038/nrg.2017.101
Solovieff, N., Cotsapas, C., Lee, P. H., Purcell, S. M. & Smoller, J. W. Pleiotropy in complex traits: challenges and strategies. Nat. Rev. Genet. 14, 483–495 (2013).
pubmed: 23752797 pmcid: 4104202 doi: 10.1038/nrg3461
Udler, M. S. et al. Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis. PLoS Med. 15, e1002654 (2018).
pubmed: 30240442 pmcid: 6150463 doi: 10.1371/journal.pmed.1002654
Sanseau, P. et al. Use of genome-wide association studies for drug repositioning. Nat. Biotechnol. 30, 317–320 (2012).
pubmed: 22491277 doi: 10.1038/nbt.2151
Nelson, M. R. et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 47, 856–860 (2015).
pubmed: 26121088 doi: 10.1038/ng.3314
Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
pubmed: 25826379 pmcid: 4380465 doi: 10.1371/journal.pmed.1001779
Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
pubmed: 30305743 pmcid: 6786975 doi: 10.1038/s41586-018-0579-z
MacArthur, J. et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res. 45, D896–D901 (2017).
pubmed: 27899670 doi: 10.1093/nar/gkw1133 pmcid: 27899670
Raychaudhuri, S. et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 44, 291–296 (2012).
pubmed: 22286218 pmcid: 3288335 doi: 10.1038/ng.1076
Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet. 45, 1452–1458 (2013).
pubmed: 24162737 pmcid: 3896259 doi: 10.1038/ng.2802
Deloukas, P. et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 45, 25–33 (2013).
pubmed: 23202125 doi: 10.1038/ng.2480 pmcid: 23202125
Willer, C. J. et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45, 1274–1283 (2013).
pubmed: 24097068 pmcid: 3838666 doi: 10.1038/ng.2797
Li, Y. et al. Genetic variants associated with deep vein thrombosis: the F11 locus. J. Thromb. Haemost. 7, 1802–1808 (2009).
pubmed: 19583818 doi: 10.1111/j.1538-7836.2009.03544.x pmcid: 19583818
Bertina, R. M. et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64–67 (1994).
pubmed: 8164741 doi: 10.1038/369064a0 pmcid: 8164741
Klarin, D. et al. Genetic analysis of venous thromboembolism in UK Biobank identifies the ZFPM2 locus and implicates obesity as a causal risk factor. Circ. Cardiovasc. Genet. 10, e001643 (2017).
pubmed: 28373160 pmcid: 5395047 doi: 10.1161/CIRCGENETICS.116.001643
Gerhardt, A. et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N. Engl. J. Med. 342, 374–380 (2000).
pubmed: 10666427 doi: 10.1056/NEJM200002103420602 pmcid: 10666427
Clarke, R. et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N. Engl. J. Med. 361, 2518–2528 (2009).
pubmed: 20032323 doi: 10.1056/NEJMoa0902604
Thanassoulis, G. et al. Genetic associations with valvular calcification and aortic stenosis. N. Engl. J. Med. 368, 503–512 (2013).
pubmed: 23388002 pmcid: 3766627 doi: 10.1056/NEJMoa1109034
McPherson, R. et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316, 1488–1491 (2007).
pubmed: 17478681 pmcid: 2711874 doi: 10.1126/science.1142447
Zhao, W. et al. Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease. Nat. Genet. 49, 1450–1457 (2017).
pubmed: 28869590 pmcid: 5844224 doi: 10.1038/ng.3943
Abifadel, M. et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet. 34, 154–156 (2003).
pubmed: 12730697 doi: 10.1038/ng1161
Lewontin, R. C. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 49, 49–67 (1964).
pubmed: 17248194 pmcid: 1210557
Frot, B., Jostins, L. & McVean, G. Graphical model selection for Gaussian conditional random fields in the presence of latent variables. J. Am. Stat. Assoc. 114, 723–734 (2018).
pubmed: 31391793 pmcid: 6636895 doi: 10.1080/01621459.2018.1434531
Evangelou, E. et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat. Genet. 50, 1412–1425 (2018).
pubmed: 30224653 pmcid: 6284793 doi: 10.1038/s41588-018-0205-x
Davey Smith, G. & Hemani, G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23, R89–R98 (2014).
pubmed: 25064373 pmcid: 4170722 doi: 10.1093/hmg/ddu328
Trochet, H. et al. Bayesian meta-analysis across genome-wide association studies of diverse phenotypes. Genet. Epidemiol. 43, 532–547 (2019).
pubmed: 30920090 doi: 10.1002/gepi.22202
Giambartolomei, C. et al. A Bayesian framework for multiple trait colocalization from summary association statistics. Bioinformatics 34, 2538–2545 (2018).
pubmed: 29579179 pmcid: 6061859 doi: 10.1093/bioinformatics/bty147
Stephens, M. A unified framework for association analysis with multiple related phenotypes. PLoS ONE 8, e65245 (2013).
pubmed: 23861737 pmcid: 3702528 doi: 10.1371/journal.pone.0065245
Richardson, T. G., Harrison, S., Hemani, G. & Davey Smith, G. An atlas of polygenic risk score associations to highlight putative causal relationships across the human phenome. eLife 8, e43657 (2019).
pubmed: 30835202 pmcid: 6400585 doi: 10.7554/eLife.43657
Ding, L. et al. Modeling of multivariate longitudinal phenotypes in family genetic studies with Bayesian multiplicity adjustment. BMC Proc. 8, S69 (2014).
pubmed: 25519340 pmcid: 4143665 doi: 10.1186/1753-6561-8-S1-S69
Wain, L. V. et al. Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank. Lancet Respir. Med. 3, 769–781 (2015).
pubmed: 26423011 pmcid: 4593935 doi: 10.1016/S2213-2600(15)00283-0

Auteurs

Adrian Cortes (A)

Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK.
Oxford Centre for Neuroinflammation, Nuffield Department of Clinical Neurosciences, Division of Clinical Neurology, John Radcliffe Hospital, University of Oxford, Oxford, UK.

Patrick K Albers (PK)

Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK.

Calliope A Dendrou (CA)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Lars Fugger (L)

Oxford Centre for Neuroinflammation, Nuffield Department of Clinical Neurosciences, Division of Clinical Neurology, John Radcliffe Hospital, University of Oxford, Oxford, UK.
MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Danish National Research Foundation Centre PERSIMUNE, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Gil McVean (G)

Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK. gil.mcvean@bdi.ox.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH